14 results on '"Hamada, Satoshi"'
Search Results
2. Effects of combined oxygen and surgical masks on inspired fraction of oxygen: relevance to COVID-19-induced respiratory failure.
- Author
-
Hamada, Satoshi, Tanabe, Naoya, and Hirai, Toyohiro
- Subjects
- *
MEDICAL masks , *RESPIRATORY insufficiency , *OXYGEN masks , *OXYGEN - Published
- 2021
- Full Text
- View/download PDF
3. Focal eosinophilic myositis with Charcot-Leyden crystal formation.
- Author
-
Hamada, Satoshi, Ueki, Shigeharu, Miyabe, Yui, Tsukino, Mitsuhiro, and Hirai, Toyohiro
- Subjects
- *
MYOSITIS , *HYPEREOSINOPHILIC syndrome , *POLYMYOSITIS , *ANTINEUTROPHIL cytoplasmic antibodies , *BASIC proteins , *CRYSTALS , *GLUTEAL muscles - Published
- 2020
- Full Text
- View/download PDF
4. Humidification via high-flow nasal cannula oxygen therapy does not generate aerosols.
- Author
-
Hamada, Satoshi, Tanabe, Naoya, and Hirai, Toyohiro
- Subjects
- *
NASAL cannula , *OXYGEN therapy , *HUMIDITY control , *AEROSOLS , *COVID-19 - Published
- 2021
- Full Text
- View/download PDF
5. A Novel Zero-Voltage and Zero-Current Switching PWM DC-DC Converter With Reduced Conduction Losses.
- Author
-
Hamada, Satoshi and Nakaoka, Mutsuo
- Subjects
- *
CASCADE converters , *ELECTRIC conductivity - Abstract
Presents a zero-voltage and zero-current switching PWM dc-dc converter with low conduction losses. Creation of interleaved two-switch forward soft-switching converter topology; Minimization of circulating current using the converter topology; Advantage of the dc-dc converter.
- Published
- 2002
- Full Text
- View/download PDF
6. Small GTPase OsRac1 Forms Two Distinct Immune Receptor Complexes Containing the PRR OsCERK1 and the NLR Pit.
- Author
-
Akamatsu, Akira, Fujiwara, Masayuki, Hamada, Satoshi, Wakabayashi, Megumi, Yao, Ai, Wang, Qiong, Kosami, Ken-ichi, Dang, Thu Thi, Kaneko-Kawano, Takako, Fukada, Fumi, Shimamoto, Ko, and Kawano, Yoji
- Subjects
- *
IMMUNE complexes , *GUANOSINE triphosphatase , *PATTERN perception receptors , *HEAT shock proteins , *CELL membranes - Abstract
Plants employ two different types of immune receptors, cell surface pattern recognition receptors (PRRs) and intracellular nucleotide-binding and leucine-rich repeat-containing proteins (NLRs), to cope with pathogen invasion. Both immune receptors often share similar downstream components and responses but it remains unknown whether a PRR and an NLR assemble into the same protein complex or two distinct receptor complexes. We have previously found that the small GTPase OsRac1 plays key roles in the signaling of OsCERK1, a PRR for fungal chitin, and of Pit, an NLR for rice blast fungus, and associates directly and indirectly with both of these immune receptors. In this study, using biochemical and bioimaging approaches, we revealed that OsRac1 formed two distinct receptor complexes with OsCERK1 and with Pit. Supporting this result, OsCERK1 and Pit utilized different transport systems for anchorage to the plasma membrane (PM). Activation of OsCERK1 and Pit led to OsRac1 activation and, concomitantly, OsRac1 shifted from a small to a large protein complex fraction. We also found that the chaperone Hsp90 contributed to the proper transport of Pit to the PM and the immune induction of Pit. These findings illuminate how the PRR OsCERK1 and the NLR Pit orchestrate rice immunity through the small GTPase OsRac1. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
7. Hyperfructosemia in sleep disordered breathing: metabolome analysis of Nagahama study.
- Author
-
Nakatsuka, Yoshinari, Murase, Kimihiko, Sonomura, Kazuhiro, Tabara, Yasuharu, Nagasaki, Tadao, Hamada, Satoshi, Matsumoto, Takeshi, Minami, Takuma, Kanai, Osamu, Takeyama, Hirofumi, Sunadome, Hironobu, Takahashi, Naomi, Nakamoto, Isuzu, Tanizawa, Kiminobu, Handa, Tomohiro, Sato, Taka-Aki, Komenami, Naoko, Wakamura, Tomoko, Morita, Satoshi, and Takeuchi, Osamu
- Subjects
- *
SLEEP disorders , *CONTINUOUS positive airway pressure , *SLEEP apnea syndromes , *DISCRIMINANT analysis - Abstract
Sleep disordered breathing (SDB), mainly obstructive sleep apnea (OSA), constitutes a major health problem due to the large number of patients. Intermittent hypoxia caused by SDB induces alterations in metabolic function. Nevertheless, metabolites characteristic for SDB are largely unknown. In this study, we performed gas chromatography-mass spectrometry-based targeted metabolome analysis using data from The Nagahama Study (n = 6373). SDB-related metabolites were defined based on their variable importance score in orthogonal partial least squares discriminant analysis and fold changes in normalized peak-intensity levels between moderate-severe SDB patients and participants without SDB. We identified 20 metabolites as SDB-related, and interestingly, these metabolites were frequently included in pathways related to fructose. Multivariate analysis revealed that moderate-severe SDB was a significant factor for increased plasma fructose levels (β = 0.210, P = 0.006, generalized linear model) even after the adjustment of confounding factors. We further investigated changes in plasma fructose levels after continuous positive airway pressure (CPAP) treatment using samples from patients with OSA (n = 60) diagnosed by polysomnography at Kyoto University Hospital, and found that patients with marked hypoxemia exhibited prominent hyperfructosemia and their plasma fructose levels lowered after CPAP treatment. These data suggest that hyperfructosemia is the abnormality characteristic to SDB, which can be reduced by CPAP treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia.
- Author
-
Tanabe, Naoya, Matsumoto, Hisako, Hamada, Satoshi, Ito, Isao, and Hirai, Toyohiro
- Subjects
- *
COVID-19 , *PNEUMONIA - Published
- 2021
- Full Text
- View/download PDF
9. Hyperfructosemia in sleep disordered breathing: metabolome analysis of Nagahama study.
- Author
-
Nakatsuka, Yoshinari, Murase, Kimihiko, Sonomura, Kazuhiro, Tabara, Yasuharu, Nagasaki, Tadao, Hamada, Satoshi, Matsumoto, Takeshi, Minami, Takuma, Kanai, Osamu, Takeyama, Hirofumi, Sunadome, Hironobu, Takahashi, Naomi, Nakamoto, Isuzu, Tanizawa, Kiminobu, Handa, Tomohiro, Sato, Taka-Aki, Komenami, Naoko, Wakamura, Tomoko, Morita, Satoshi, and Takeuchi, Osamu
- Subjects
- *
SLEEP disorders , *CONTINUOUS positive airway pressure , *SLEEP apnea syndromes , *DISCRIMINANT analysis - Abstract
Sleep disordered breathing (SDB), mainly obstructive sleep apnea (OSA), constitutes a major health problem due to the large number of patients. Intermittent hypoxia caused by SDB induces alterations in metabolic function. Nevertheless, metabolites characteristic for SDB are largely unknown. In this study, we performed gas chromatography-mass spectrometry-based targeted metabolome analysis using data from The Nagahama Study (n = 6373). SDB-related metabolites were defined based on their variable importance score in orthogonal partial least squares discriminant analysis and fold changes in normalized peak-intensity levels between moderate-severe SDB patients and participants without SDB. We identified 20 metabolites as SDB-related, and interestingly, these metabolites were frequently included in pathways related to fructose. Multivariate analysis revealed that moderate-severe SDB was a significant factor for increased plasma fructose levels (β = 0.210, P = 0.006, generalized linear model) even after the adjustment of confounding factors. We further investigated changes in plasma fructose levels after continuous positive airway pressure (CPAP) treatment using samples from patients with OSA (n = 60) diagnosed by polysomnography at Kyoto University Hospital, and found that patients with marked hypoxemia exhibited prominent hyperfructosemia and their plasma fructose levels lowered after CPAP treatment. These data suggest that hyperfructosemia is the abnormality characteristic to SDB, which can be reduced by CPAP treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. Prognosis of patients with systemic sclerosis-related interstitial lung disease on the lung transplant waiting list: a retrospective study.
- Author
-
Nakayama, Yoichi, Nakashima, Ran, Handa, Tomohiro, Ohsumi, Akihiro, Yamada, Yoshito, Nakajima, Daisuke, Yutaka, Yojiro, Tanaka, Satona, Hamada, Satoshi, Ikezoe, Kohei, Tanizawa, Kiminobu, Shirakashi, Mirei, Hiwa, Ryosuke, Tsuji, Hideaki, Kitagori, Koji, Akizuki, Shuji, Yoshifuji, Hajime, Date, Hiroshi, and Morinobu, Akio
- Subjects
- *
INTERSTITIAL lung diseases , *SURVIVAL analysis (Biometry) , *LUNG transplantation , *LUNGS , *VITAL capacity (Respiration) , *LUNG diseases , *PROGNOSIS - Abstract
Advanced systemic sclerosis-associated interstitial lung disease (SSc-ILD) can be treated with lung transplantation. There is limited data on lung transplantation outcomes in patients with SSc-ILD, in non-Western populations.We assessed survival data of patients with SSc-ILD, on the lung transplant (LT) waiting list, and evaluated post-transplant outcomes in patients from an Asian LT center. In this single-center retrospective study, 29 patients with SSc-ILD, registered for deceased LT at Kyoto University Hospital, between 2010 and 2022, were identified. We investigated post-transplant outcomes in recipients who underwent LT for SSc-ILD, between February 2002 and April 2022. Ten patients received deceased-donor LT (34%), two received living-donor LT (7%), seven died waiting for LT (24%), and ten survived on the waiting list (34%). Median duration from registration to deceased-donor LT was 28.9 months and that from registration to living-donor LT or death was 6.5 months. Analysis of 15 recipients showed improved forced vital capacity with a median of 55.1% at baseline, 65.8% at 6 months, and 80.3% at 12 months post-transplant. The 5-year survival rate for post-transplant patients with SSc-ILD was 86.2%. The higher post-transplant survival rate at our institute than previously reported suggests that lung transplantation is acceptable in Asian patients with SSc-ILD. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. Population pharmacokinetic modeling of GS‐441524, the active metabolite of remdesivir, in Japanese COVID‐19 patients with renal dysfunction.
- Author
-
Sukeishi, Asami, Itohara, Kotaro, Yonezawa, Atsushi, Sato, Yuki, Matsumura, Katsuyuki, Katada, Yoshiki, Nakagawa, Takayuki, Hamada, Satoshi, Tanabe, Naoya, Imoto, Eishi, Kai, Shinichi, Hirai, Toyohiro, Yanagita, Motoko, Ohtsuru, Shigeru, Terada, Tomohiro, and Ito, Isao
- Subjects
- *
JAPANESE people , *COVID-19 , *CORONAVIRUS disease treatment , *KIDNEY diseases , *REMDESIVIR , *EXTRACORPOREAL membrane oxygenation - Abstract
Remdesivir, a prodrug of the nucleoside analog GS‐441524, plays a key role in the treatment of coronavirus disease 2019 (COVID‐19). However, owing to limited information on clinical trials and inexperienced clinical use, there is a lack of pharmacokinetic (PK) data in patients with COVID‐19 with special characteristics. In this study, we aimed to measure serum GS‐441524 concentrations and develop a population PK (PopPK) model. Remdesivir was administered at a 200 mg loading dose on the first day followed by 100 mg from day 2, based on the package insert, in patients with an estimated glomerular filtration rate (eGFR) greater than or equal to 30 ml/min. In total, 190 concentrations from 37 Japanese patients were used in the analysis. The GS‐441524 trough concentrations were significantly higher in the eGFR less than 60 ml/min group than in the eGFR greater than or equal to 60 ml/min group. Extracorporeal membrane oxygenation in four patients hardly affected the total body clearance (CL) and volume of distribution (Vd) of GS‐441524. A one‐compartment model described serum GS‐441524 concentration data. The CL and Vd of GS‐441524 were significantly affected by eGFR readjusted by individual body surface area and age, respectively. Simulations proposed a dose regimen of 200 mg on day 1 followed by 100 mg once every 2 days from day 2 in patients with an eGFR of 30 ml/min or less. In conclusion, we successfully established a PopPK model of GS‐441524 using retrospectively obtained serum GS‐441524 concentrations in Japanese patients with COVID‐19, which would be helpful for optimal individualized therapy of remdesivir. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
12. Zero voltage soft-commutation PWM DC-DC converter with saturable reactor switch-cascaded diode...
- Author
-
Sun, Junming, Guo, Bin, Hamada, Satoshi, Yoshitsugu, Junji, and Nakaoka, Mutsuo
- Subjects
- *
ELECTRIC current converters , *ELECTRIC circuit analysis - Abstract
Presents an improved single-ended push-pull (SEPP) half-bridge type zero-voltage soft-switching pulse width modulation power converter. Features of the converter; Circuit description and operating analysis.
- Published
- 1998
- Full Text
- View/download PDF
13. Nocturnal hypercapnia with daytime normocapnia in patients with advanced pulmonary arterial hypertension awaiting lung transplantation.
- Author
-
Nakatsuka, Yoshinari, Chen-Yoshikawa, Toyofumi, Kinoshita, Hideyuki, Aoyama, Akihiro, Kubo, Hiroyasu, Murase, Kimihiko, Hamada, Satoshi, Takeyama, Hirofumi, Minami, Takuma, Takahashi, Naomi, Tanizawa, Kiminobu, Handa, Tomohiro, Hirai, Toyohiro, Date, Hiroshi, and Chin, Kazuo
- Subjects
- *
PULMONARY hypertension , *LUNG transplantation , *HYPERCAPNIA , *CARDIAC output , *PARTIAL pressure - Abstract
Background: Pulmonary arterial hypertension (PAH) is frequently complicated by sleep disordered breathing (SDB), and previous studies have largely focused on hypoxemic SDB. Even though nocturnal hypercapnia was shown to exacerbate pulmonary hypertension, the clinical significance of nocturnal hypercapnia among PAH patients has been scarcely investigated. Method: Seventeen patients with PAH were identified from 246 consecutive patients referred to Kyoto University Hospital for the evaluation of lung transplant registration from January 2010 to December 2017. Included in this study were 13 patients whose nocturnal transcutaneous carbon dioxide partial pressure (PtcCO2) monitoring data were available. Nocturnal hypercapnia was diagnosed according to the guidelines of the American Academy of Sleep Medicine. Associations of nocturnal PtcCO2 measurements with clinical features, the findings of right heart catheterization and pulmonary function parameters were evaluated. Results: Nocturnal hypercapnia was diagnosed in six patients (46.2%), while no patient had daytime hypercapnia. Of note, nocturnal hypercapnia was found for 5 out of 6 patients with idiopathic PAH (83.3%). Mean nocturnal PtcCO2 levels correlated negatively with the percentage of predicted total lung capacity (TLC), and positively with cardiac output and cardiac index. Conclusion: Nocturnal hypercapnia was prevalent among advanced PAH patients who were waiting for lung transplantation, and associated with %TLC. Nocturnal hypercapnia was associated with the increase in cardiac output, which might potentially worsen pulmonary hypertension especially during sleep. Further studies are needed to investigate hemodynamics during sleep and to clarify whether nocturnal hypercapnia can be a therapeutic target for PAH patients. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
14. Impact of Obstructive Sleep Apnea on Liver Fat Accumulation According to Sex and Visceral Obesity.
- Author
-
Toyama, Yoshiro, Tanizawa, Kiminobu, Kubo, Takeshi, Chihara, Yuichi, Harada, Yuka, Murase, Kimihiko, Azuma, Masanori, Hamada, Satoshi, Hitomi, Takefumi, Handa, Tomohiro, Oga, Toru, Chiba, Tsutomu, Mishima, Michiaki, and Chin, Kazuo
- Subjects
- *
FATTY liver , *SLEEP apnea syndrome treatment , *BIOACCUMULATION , *VISCERAL reflex , *REFLEXES , *OBESITY - Abstract
Rationale: Associations between obstructive sleep apnea (OSA) and liver fat accumulation have been frequently investigated because both morbidities are common. Visceral fat was reported to be closely related to OSA and liver fat accumulation. Recently, sex differences in the association between OSA and mortality have gained much attention. Objectives: To investigate the associations among OSA, liver fat accumulation as determined by computed tomography, and visceral fat area and their sex differences. Methods: Studied were 188 males and 62 females who consecutively underwent polysomnography and computed tomography. Results: Although the apnea-hypopnea index was positively correlated with liver fat accumulation in the total males, none of the OSA-related factors was independently associated with liver fat accumulation in either the total male or female participants in the multivariate analyses. When performing subanalyses using a specific definition for Japanese of obesity or visceral obesity (body mass index (BMI) ≥25 kg/m2 or visceral fat area ≥100 cm2), in only males without visceral obesity, percent sleep time with oxygen saturation <90%, in addition to BMI, insulin resistance, and serum triglyceride values, was independently correlated with liver fat accumulation (R2 = 15.1%, P<0.001). In males, percent sleep time of oxygen saturation <90% was also a determining factor for alanine aminotransferase values regardless of visceral fat area. In contrast, OSA was not associated with liver fat accumulation or alanine aminotransferase values in females whether or not visceral obesity was absent. Conclusions: Sex differences in the visceral fat-dependent impact of OSA on liver fat accumulation existed. Although the mechanisms are not known and ethnic differences may exist in addition to the specific criteria of visceral obesity in Japan, the treatment of male patients with OSA might be favorable from the viewpoint of preventing liver fat accumulation and liver dysfunction even in patients without obvious visceral fat accumulation. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.